Arbutus Biopharma (ABUS) Institutional Ownership $3.55 +0.04 (+1.14%) Closing price 06/10/2025 04:00 PM EasternExtended Trading$3.60 +0.05 (+1.38%) As of 06/10/2025 06:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Arbutus Biopharma (NASDAQ:ABUS)CurrentInstitutional OwnershipPercentage43.79%Number ofInstitutional Buyers(last 12 months)67TotalInstitutional Inflows(last 12 months)$56.49MNumber ofInstitutional Sellers(last 12 months)28TotalInstitutional Outflows(last 12 months)$11.29M Get ABUS Insider Trade Alerts Want to know when executives and insiders are buying or selling Arbutus Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ABUS Institutional Buying and Selling by Quarter Arbutus Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/29/2025 Rhumbline Advisers200,757$701K0.0%+6.4%0.105% 5/28/2025 Wealth Management Associates Inc.96,420$337K0.1%+58.0%0.050% 5/16/2025 Woodline Partners LP2,655,738$9.27M0.1%+173.3%1.387% 5/16/2025 Goldman Sachs Group Inc.2,075,948$7.25M0.0%+290.3%1.084% 5/16/2025 Two Seas Capital LP9,465,956$33.04M1.0%+8.3%4.944% 5/16/2025 Adage Capital Partners GP L.L.C.1,575,941$5.50M0.0%-4.5%0.823% 5/16/2025 ADAR1 Capital Management LLC1,879,114$6.56M1.2%+20.9%0.981% 5/14/2025 Rafferty Asset Management LLC82,864$289K0.0%-43.6%0.043% 5/14/2025 MetLife Investment Management LLC88,887$310K0.0%+8.9%0.046% 5/14/2025 EntryPoint Capital LLC18,730$65K0.0%N/A0.010% Get the Latest News and Ratings for ABUS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arbutus Biopharma and its competitors with MarketBeat's FREE daily newsletter. 5/13/2025 Aberdeen Group plc467,383$1.63M0.0%N/A0.244% 5/12/2025 Nuveen LLC313,307$1.09M0.0%N/A0.164% 5/12/2025 Invesco Ltd.139,462$487K0.0%+99.7%0.073% 5/12/2025 Mitsubishi UFJ Asset Management Co. Ltd.76,031$265K0.0%+9.1%0.040% 5/9/2025 Deutsche Bank AG146,863$513K0.0%-14.5%0.077% 5/9/2025 Vanguard Group Inc.8,953,823$31.25M0.0%-0.3%4.676% 5/8/2025 XTX Topco Ltd72,412$253K0.0%+37.7%0.038% 5/7/2025 Zurcher Kantonalbank Zurich Cantonalbank 84,163$294K0.0%-6.1%0.044% 5/2/2025 SBI Securities Co. Ltd.78,894$275K0.0%+9.2%0.041% 4/29/2025 Bank of New York Mellon Corp348,797$1.22M0.0%-1.3%0.182% 4/28/2025 Teacher Retirement System of Texas38,248$133K0.0%-9.2%0.020% 4/17/2025 Cyndeo Wealth Partners LLC10,000$35K0.0%N/A0.005% 4/8/2025 Rhumbline Advisers200,757$701K0.0%+6.4%0.105% 3/24/2025 Wellington Management Group LLP513,302$1.68M0.0%+3.3%0.271% 2/18/2025 Two Seas Capital LP8,740,956$28.58M2.2%+4.2%4.613% 2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC103,943$340K0.0%-46.9%0.055% 2/17/2025 Whitefort Capital Management LP13,241,916$43.30M20.8%+2.9%6.988% 2/17/2025 Woodline Partners LP971,628$3.18M0.0%+45.4%0.513% 2/17/2025 Saba Capital Management L.P.887,993$2.90M0.1%+31.3%0.469% 2/17/2025 Rafferty Asset Management LLC146,803$480K0.0%+27.6%0.077% 2/17/2025 ProShare Advisors LLC50,121$164K0.0%+29.3%0.026% 2/17/2025 Millennium Management LLC343,028$1.12M0.0%+36.7%0.181% 2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.89,397$292K0.0%+10.2%0.047% 2/17/2025 LMR Partners LLP158,249$517K0.0%-19.7%0.084% 2/17/2025 Hudson Bay Capital Management LP1,112,500$3.64M0.0%+8.0%0.587% 2/17/2025 Deutsche Bank AG171,766$562K0.0%+77.9%0.091% 2/17/2025 Balyasny Asset Management L.P.41,690$136K0.0%N/A0.022% 2/17/2025 Bank of America Corp DE361,304$1.18M0.0%+90.8%0.191% 2/17/2025 BNP Paribas Financial Markets247,996$811K0.0%-19.1%0.131% 2/17/2025 Ameriprise Financial Inc.18,917$62K0.0%N/A0.010% The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad)Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profitable trends in tech … well ahead of Wall Street. Like when he called Nvidia at a mere 80 cents a share. Or Bitcoin when it was trading for just $300. Throughout his illustrious career … Michael has given his followers almost 150 different chances to register triple-digit gains.Now he's identified his next potential winner. Click here to find out more.2/14/2025 Mercer Global Advisors Inc. ADV20,500$67K0.0%N/A0.011% 2/14/2025 Northern Trust Corp1,330,683$4.35M0.0%+8.3%0.702% 2/14/2025 Boothbay Fund Management LLC162,277$531K0.0%-73.5%0.086% 2/14/2025 Susquehanna Fundamental Investments LLC202,541$662K0.0%N/A0.107% 2/14/2025 Virtus ETF Advisers LLC19,970$65K0.0%-31.5%0.011% 2/14/2025 Two Sigma Securities LLC19,475$64K0.0%N/A0.010% 2/14/2025 Two Seas Capital LP8,740,956$28.58M2.5%+4.2%4.613% 2/14/2025 Adage Capital Partners GP L.L.C.1,650,941$5.40M0.0%-43.1%0.871% 2/14/2025 Price T Rowe Associates Inc. MD56,452$185K0.0%+18.1%0.030% 2/14/2025 BlackBarn Capital Partners LP2,341,871$7.66M0.4%+13.1%1.236% 2/14/2025 Hsbc Holdings PLC16,994$55K0.0%N/A0.009% 2/13/2025 XTX Topco Ltd52,581$172K0.0%+75.2%0.028% 2/13/2025 Barclays PLC298,253$975K0.0%+9.6%0.157% 2/13/2025 Rockefeller Capital Management L.P.106,615$349K0.0%+69.2%0.056% 2/13/2025 Quinn Opportunity Partners LLC404,879$1.32M0.1%+72.2%0.214% 2/13/2025 Raymond James Financial Inc.10,504$34K0.0%N/A0.006% 2/13/2025 Legal & General Group Plc118,693$388K0.0%-18.6%0.063% 2/13/2025 Invesco Ltd.69,831$228K0.0%+5.7%0.037% 2/13/2025 ADAR1 Capital Management LLC1,554,802$5.08M1.0%-25.6%0.821% 2/13/2025 Bank of Montreal Can455,880$1.49M0.0%+3.5%0.241% 2/13/2025 Wells Fargo & Company MN70,599$231K0.0%+44.6%0.037% 2/12/2025 Rangeley Capital LLC1,459,000$4.77M4.3%N/A0.770% 2/12/2025 Geode Capital Management LLC3,482,136$11.39M0.0%+1.0%1.838% 2/12/2025 Franklin Resources Inc.92,159$301K0.0%N/A0.049% 2/12/2025 Alliancebernstein L.P.120,240$393K0.0%-12.6%0.063% 2/12/2025 Wellington Management Group LLP513,302$1.68M0.0%+3.3%0.271% 2/12/2025 JPMorgan Chase & Co.896,258$2.93M0.0%+900.4%0.473% 2/12/2025 Mitsubishi UFJ Asset Management Co. Ltd.69,660$238K0.0%-15.0%0.037% 2/11/2025 Corebridge Financial Inc.72,632$238K0.0%-7.0%0.038% 2/11/2025 Vanguard Group Inc.8,980,864$29.37M0.0%+0.7%4.739% 2/11/2025 KLP Kapitalforvaltning AS25,600$84K0.0%N/A0.014% 2/11/2025Corbin Capital Partners L.P.682,487$2.23M3.7%-20.0%0.360% 2/11/2025 Teacher Retirement System of Texas42,144$138K0.0%+18.7%0.022% 2/11/2025 Xponance Inc.10,486$34K0.0%N/A0.006% 2/11/2025 Intech Investment Management LLC57,084$187K0.0%+54.9%0.030% 2/10/2025 Cibc World Markets Corp13,672$45K0.0%N/A0.007% 2/7/2025 E Fund Management Co. Ltd.10,385$34K0.0%N/A0.005% 2/6/2025 Raymond James Financial Inc.10,504$34K0.0%N/A0.006% 2/6/2025 Charles Schwab Investment Management Inc.1,222,201$4.00M0.0%+0.8%0.645% 2/6/2025 SBI Securities Co. Ltd.72,280$236K0.0%N/A0.038% 2/5/2025 Verus Capital Partners LLC19,350$63K0.0%-28.1%0.010% 1/30/2025 Rhumbline Advisers188,598$617K0.0%+6.0%0.100% 1/24/2025 China Universal Asset Management Co. Ltd.40,179$131K0.0%+10.7%0.021% 1/22/2025 PFG Investments LLC14,200$46K0.0%-26.0%0.007% 1/17/2025 SG Americas Securities LLC69,119$226K0.0%+30.7%0.036% 1/17/2025 Clear Harbor Asset Management LLC79,761$261K0.0%+6.7%0.042% 1/16/2025 Ballentine Partners LLC31,121$102K0.0%N/A0.016% 12/26/2024 JPMorgan Chase & Co.89,586$345K0.0%+11.0%0.047% 12/19/2024 Principal Financial Group Inc.13,755$53K0.0%-47.3%0.007% 11/19/2024 Barclays PLC272,029$1.05M0.0%+466.3%0.144% Watch This Robotics Demo Before July 23rd (Ad)Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo…11/16/2024 Geode Capital Management LLC3,448,600$13.28M0.0%+4.1%1.820% 11/15/2024 Barclays PLC272,029$1.05M0.0%+466.3%0.144% 11/15/2024 XTX Topco Ltd30,013$116K0.0%+76.2%0.016% 11/15/2024 Jane Street Group LLC66,910$258K0.0%-67.1%0.035% 11/15/2024 Wellington Management Group LLP496,818$1.91M0.0%+4.6%0.262% 11/15/2024 State Street Corp4,407,133$16.97M0.0%+50.2%2.326% 11/15/2024 Janus Henderson Group PLC60,900$234K0.0%N/A0.032% 11/15/2024 Centiva Capital LP40,000$154K0.0%-24.2%0.021% 11/14/2024 Rockefeller Capital Management L.P.63,000$243K0.0%N/A0.033% 11/14/2024 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC195,843$754K0.0%N/A0.103% (Data available from 1/1/2016 forward) ABUS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ABUS shares? During the previous two years, 96 institutional investors and hedge funds held shares of Arbutus Biopharma. The most heavily invested institutionals were Whitefort Capital Management LP ($43.30M), Two Seas Capital LP ($33.04M), Vanguard Group Inc. ($31.25M), State Street Corp ($16.97M), Geode Capital Management LLC ($11.39M), Woodline Partners LP ($9.27M), and BlackBarn Capital Partners LP ($7.66M).Learn more on ABUS's institutional investors. What percentage of Arbutus Biopharma stock is owned by institutional investors? 43.79% of Arbutus Biopharma stock is owned by institutional investors. Learn more on ABUS's institutional investor holdings. Which institutional investors have been buying Arbutus Biopharma stock? Of the 77 institutional investors that purchased Arbutus Biopharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Woodline Partners LP ($1.99M), Rubric Capital Management LP ($1.68M), Goldman Sachs Group Inc. ($1.54M), Hudson Bay Capital Management LP ($1.50M), State Street Corp ($1.47M), Rangeley Capital LLC ($1.46M), and Two Seas Capital LP ($1.43M). How much institutional buying is happening at Arbutus Biopharma? Institutional investors have bought a total of 19,233,057 shares in the last 24 months. This purchase volume represents approximately $62.66M in transactions. Which Arbutus Biopharma major shareholders have been selling company stock? Of the 38 institutional investors that sold Arbutus Biopharma stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Adage Capital Partners GP L.L.C. ($1.33M), Rubric Capital Management LP ($799.22K), ADAR1 Capital Management LLC ($534.52K), Boothbay Fund Management LLC ($450K), Whitefort Capital Management LP ($334.91K), FourWorld Capital Management LLC ($251.06K), and Corbin Capital Partners L.P. ($170.82K). How much institutional selling is happening at Arbutus Biopharma? Institutional investors have sold a total of 5,000,371 shares in the last 24 months. This volume of shares sold represents approximately $15.14M in transactions. Related Companies LYEL Major Shareholders APLS Major Shareholders OGN Major Shareholders HCM Major Shareholders IBRX Major Shareholders AMRX Major Shareholders XENE Major Shareholders MIRM Major Shareholders ARWR Major Shareholders AAPG Major Shareholders This page (NASDAQ:ABUS) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arbutus Biopharma Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arbutus Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
